On January 10, 2025, NeuroOne Medical Technologies Corporation filed an 8-K form with the Securities and Exchange Commission, announcing certain preliminary financial results for the first fiscal quarter of 2025, which ended on December 31, 2024. The company revealed unaudited revenue figures and stated that the estimates provided are not a comprehensive representation of its […]